mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.007 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.007 |
mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.007 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.008 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.008 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.009 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.009 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.009 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.01 |